Cardinal Health (CAH) upgraded to Buy after strong Q2 FY2026 results, higher guidance, and $750M buybacks. Read here for more ...

The pharmaceutical distributor and health services company raises its guidance for the second time.

Cardinal Health raised its annual outlook again after logging higher profit and revenue in its fiscal second quarter.

Cardinal Health has reported that revenue for its Other segment, which includes at-Home Solutions, increased 34% to $1.7 billion for its second quarter fiscal year 2026. Profit for ...

Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, ...

Cardinal Health CEO Jason Hollar talked to us about how the Dublin HQ and Columbus-area warehouses help drive sales, profits and a share price that keep breaking records.

Cardinal Health reports strong Q2 results and raises fiscal 2026 outlook. Sales increased by 19%, beating estimates.

Only 10 of 30 companies saw a drop in shares over the course of 2025, and only Heartland Bank was delisted after it was ...

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty drug ...

The Columbus Zoo and Aquarium has appointed Stacey Burbure of AEP and Jessica Mayer of Cardinal Health to its board, adding ...

Target, CVS and Rite Aid are pulling products from shelves after federal investigators found unsanitary conditions and recommended a recall. By Rebecca Carballo An agreement between attorneys general ...